'Octomom' doctor has medical licence revoked

By Admin
Share
A fertility doctor who injected a woman with six times the normal number of embryos is to lose his medical licence next month. Nadya Suleman has become...

A fertility doctor who injected a woman with six times the normal number of embryos is to lose his medical licence next month.

Nadya Suleman has become famed as the Californian ‘octomom’ who in 2009 successfully gave birth to octuplets; only the second person in the US to do so.

The state’s medical board ruled that Michael Kamrava, Suleman’s fertility doctor, was guilty of being grossly negligent after he implanted an “excessive number” of embryos into Suleman.

READ MORE FROM THE WDM CONTENT NETWORK:

To read the latest edition of Healthcare Global, click here

Although Suleman became a media sensation after the successful birth, it was quickly discovered that she was an unemployed, single mother already with six children.

Kamrava helped Suleman to conceive all 14 of her children through repeated in-vitro fertility (IVF) treatments.

The Medical Board of California made the decision to revoke his medical licence as it said “public protection is paramount.”

Kamrava was also found to be negligent of his treatment of two other fertility patients; a woman who suffered severe complications after becoming pregnant with quadruplets and another who received a diagnoses of advanced ovarian cancer after undergoing fertility treatment.

The legal team representing Kamrava argued that Suleman had failed to follow through with terminating an excessive number of feotuses.

But these arguments were rejected by the board and they said: “To assign even a scintilla of responsibility to a patient who becomes pregnant and then elects not to follow through with a procedure that may jeopardise her (and possibly her family's) prized objective is troubling.”

Dr Kamrava’s licence will be officially revoked on July 1 2011

Share

Featured Articles

NTT & Olympus: World's First Cloud Endoscopy System

NTT and medical technology company Olympus put on a demonstration, showing the IOWN APN's low-latency capability, for the first cloud endoscopy system

Richter BioLogics' New Biopharmaceutical GMP Facility

Richter BioLogics GmbH & Co KG's a new biopharmaceutical GMP facility in Germany will boost production capabilities and local employment

GE HealthCare's Pilot Study Shows Value of Portrait Mobile

A pilot study from GE Healthcare has shown the value of Portrait Mobile Continuous Monitoring Solution, a leap in post-surgical monitoring efficiency

50% of Teens to be Affected by Myopia Globally by 2050

Telehealth & COVID-19

NVIDIA’s AI Insights for Diabetes Prevention with GluFormer

Technology & AI

Novo Nordisk's CagriSema Next Gen Weight-Loss Treatment

Medical Devices & Pharma